Shandong Science ›› 2023, Vol. 36 ›› Issue (4): 42-51.doi: 10.3976/j.issn.1002-4026.2023.04.006

• Traffic and Transportation • Previous Articles     Next Articles

The mechanism of Gandouling tablet in alleviating hepatolenticular degeneration neuroinflammation via the regulation of the TLR4/NF-κB/NLRP3 signaling pathway

WEN Yuya1(), DONG Ting2,*(), JIANG Zhangsheng1, CHEN Jie1, TIAN Liwei1, ZHAO Chenling1, TANG Lulu2   

  1. 1. Graduate School of Anhui University of Chinese Medicine, Hefei 230038, China
    2. The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China
  • Received:2023-01-07 Online:2023-08-20 Published:2023-08-03

Abstract:

This study aimed to investigate the effect of Gandouling tablet on neuroinflammation in hepatolenticular degeneration in TX mice and mechanism of generating CuCl2-induced microglia inflammatory response based on TLR4/NF-κB/NLRP3 signaling pathway. TX mice were divided into control, model, Gandouling tablet low-dose, Gandouling tablet medium-dose, Gandouling tablet high-dose, and penicilamine groups. BV2 cells were divided into control, model, Gandouling tablet, TAK-242, and Gandouling tablet + TAK-242 groups. Hematoxylin and eosin staining was performed to detect histopathological changes in the hippocampus of mice in each group. Western blot was used to detect the expressions of TLR4, p65, NLRP3, and IL-1β in hippocampal tissue and BV2 cells of mice in each group. Enzyme-linked immunosorbent assay was performed to quantify TNF-α, IL-1β, and IL-6 levels in hippocampal tissue and BV2 cells of mice in each group. Real-time polymerase chain reaction was used to determine the expression of TLR4, p65, NLRP3, TNF-α, and IL-1β mRNA in all groups of BV2 cells. Compared with the control group, hippocampal tissue in the model group showed considerable inflammatory damage; increased protein expressions of TLR4, p65, NLRP3, and IL-1β; and significantly increased levels of TNF-α, IL-1β, and IL-6 (P<0.05). Compared with the model group, the pathological damage of hippocampal tissue improved in both Gandouling tablet and penicillamine groups, and the effect of Gandouling tablet in the Gandouling tablet high-dose group was more prominent than that in the other groups. The Gandouling tablet and TAK-242 groups inhibited the activation of BV2 cells. Additionally, the expression of TLR4, p65, NLRP3, and IL-1β protein and mRNA were significantly reduced in these two groups as compared with the model group, and TNF-α, IL-1β and IL-6 levels were significantly decreased (P < 0.05). Gandouling tablet can alleviate hippocampal inflammation and inhibit CuCl2-induced hyperactivation of BV2 cells in TX mice probably by downregulating TLR4/NF-κB/NLRP3 signaling pathway.

Key words: Gandouling tablet, hepatolenticular degeneration, TLR4/NF-κB/NLRP3, neuroinflammation, action mechanism

CLC Number: 

  • R285